Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Abstract Over the past 5 years, public interest in the potential health benefits of cannabidiol (CBD) has increased exponentially, and…
Abstract Over the past 5 years, public interest in the potential health benefits of cannabidiol (CBD) has increased exponentially, and…
Abstract Mutations in SYNGAP1 are associated with developmental delay, epilepsy, and autism spectrum disorder (ASD). Epilepsy is often drug‐resistant in…
Abstract Use of medical marijuana is increasing in the United States and older adults are the fastest growing user group.…
Abstract Objective: To determine the safety and tolerability of escalating doses of three cannabis oil formulations, containing predominantly CBD, THC,…
Abstract Background: Across the nation, growing numbers of individuals are exploring the use of cannabis for medical or recreational purposes,…
Abstract Introduction: Synthetic cannabinoid mixtures have been easily accessible for years, leading to the belief that these products were natural…
Abstract Background: Chronic pain affects a significant proportion of the population and presents a major challenge to clinicians and pain…
Abstract Therapeutic use of cannabinoids, the main active ingredients of Cannabis sativa L., is often hindered by their limited bioavailability…
Abstract Background: Pediatric epilepsy, including treatment-resistant forms, has a major effect on the quality of life, morbidity, and mortality of…
Abstract Background: Despite growing interest in the therapeutic use of cannabis to manage chronic pain, only limited data that address…